La Jolla Institute receives $ 4.5 mill Cancer Moonshot award
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million
Listen to Dr. Ezra Cohen, professor of medicine at University of California San Diego School of Medicine, and Dr. Stephen
LA JOLLA, CA—Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current
A highlight reel from Dr. Matthias von Herrath’s Life Without Disease Lecture on October 4, 2018.
You’ll be among the first to hear about the latest on our research, organizational news and events. The LJI Communications
When the first prototype designed to follow immune cells in the arteries of living mice failed, Sara McArdle, Ph.D., nabbed
The composition of an immune system varies not just from person to person, but over time—shifting as our health changes,
When Novo Nordisk, a global pharmaceutical company headquartered in Denmark and best known for its diabetes products, wanted to reinvigorate
Turnstone Planning to Initiate Phase I/II Clinical Trial Utilizing Personalized Neoantigen Therapy with Proprietary MG1 Viral Platform in 2019 NEW
LA JOLLA, CA—Neutrophils—short-lived, highly mobile and versatile—outnumber all other immune cells circulating through the blood stream. Yet, despite the cells’
When research intern Hope Steele joined mentor Rana Herro, Ph.D., for nine weeks to gain some hands-on-experience in a lab,
LA JOLLA, CA—The National Institute of General Medical Sciences (NIGMS) has awarded La Jolla Institute’s Ferhat Ay, Ph.D., $ 2.24